[1]卓思源,NICOLA Cirillo(澳大利亚),杨小如,等.逍遥散加味联合曲安奈德治疗口腔扁平苔藓肝郁血瘀证疗效研究[J].陕西中医,2024,(7):918-921.[doi:DOI:10.3969/j.issn.1000-7369.2024.07.012]
　ZHUO Siyuan,NICOLA Cirillo,YANG Xiaoru,et al.Curative effect study on Xiaoyao powder combined with triamcinolone 、acetonide in treatment oral lichen planus of Ganyu Xueyu[J].,2024,(7):918-921.[doi:DOI:10.3969/j.issn.1000-7369.2024.07.012]
点击复制

逍遥散加味联合曲安奈德治疗口腔扁平苔藓肝郁血瘀证疗效研究
分享到：

《陕西中医》[ISSN:1000-7369/CN:61-1281/TN]

卷:
期数:
2024年7期
页码:
918-921
栏目:
临床研究
出版日期:
2024-07-05

文章信息/Info

Title:
Curative effect study on Xiaoyao powder combined with triamcinolone 、acetonide in treatment oral lichen planus of Ganyu Xueyu
作者:
卓思源1; NICOLA Cirillo2(澳大利亚); 杨小如1; 3; 何 昕4
(1.安徽中医药大学第一附属医院,安徽 合肥 230031; 2.墨尔本大学口腔健康学院,墨尔本 3000; 3.山南市人民医院,西藏 山南 856000; 4.安徽医科大学附属口腔医院,安徽 合肥 230036)
Author(s):
ZHUO Siyuan; NICOLA Cirillo; YANG Xiaoru; HE Xin
(The First Affiliated Hospital of Anhui University of Chinese Medicine,Hefei 230031,China)
关键词:
口腔扁平苔藓;  肝郁血瘀;  逍遥散加味;  曲安奈德;  唾液炎症因子;  免疫功能;  不良反应
Keywords:
Oral lichen planus;  Ganyu Xueyu;  Xiaoyaosan flavored;  Triamcinolone acetonide;  Salivary inflammatory factors;  Immune function;  Adverse reactions
分类号:
R 246.83
DOI:
DOI:10.3969/j.issn.1000-7369.2024.07.012
文献标志码:
A
摘要:
目的:探讨逍遥散加味联合曲安奈德治疗口腔扁平苔藓(OLP)肝郁血瘀证的疗效及对唾液炎症因子的影响。方法:选取84例OLP肝郁血瘀证患者按照随机数字表法分为观察组(n=42)和对照组(n=42)。对照组予曲安奈德注射液1 ml混合等量2%盐酸利多卡因注射液于病损边缘局部注射,观察组在对照组治疗基础上予以逍遥散加味治疗,治疗8周后比较两组的临床疗效、症状评分、唾液炎症因子、免疫功能及不良反应发生情况,记录治疗后6个月的复发情况。结果:观察组临床总有效率为92.86%高于对照组的76.19%(P<0.05)。观察组治疗后主观和客观症状评分低于对照组(P<0.05)。观察组治疗后唾液白介素-6(IL-6)、白介素-8(IL-8)、肿瘤坏死因子-α(TNF-α)水平低于对照组(P<0.05)。观察组治疗后CD4+、CD4+/CD8+水平高于对照组,CD8+水平明显低于对照组(P<0.05)。两组不良反应总发生率比较,差异无统计学意义(P>0.05)。观察组复发率明显低于对照组(P<0.05)。结论:逍遥散加味联合曲安奈德可有效提高OLP肝郁血瘀证患者的治疗效果,进一步缓解患者的临床症状,降低复发率及唾液炎症因子表达水平,提高机体免疫功能,安全性较好。
Abstract:
Objective:To explore curative effect of modified Xiaoyao powder combined with triamcinolone acetonide in treatment of oral lichen planus(OLP)with Ganyu Xueyu syndrome and its effect on salivary inflammatory factors.Methods:Eighty-four patients with OLP of Ganyu Xueyu were selected and divided into observation group(n=42)and control group(n=42)according to random number table method.The control group were treated with triamcinolone acetonide injection 1 ml mixed with the same amount of 2% lidocaine hydrochloride injection on edge of the lesion.The observation group were treated with Xiaoyao powder on the basis of the control group.After 8 weeks of treatment,clinical efficacy,symptom score,salivary inflammatory factors,immune function and adverse reactions of the two groups were compared,and recurrence of 6 months after treatment were recorded.Results:The total effective rate of the observation group was 92.86% higher than 76.19% of the control group(P<0.05).The scores of subjective and objective symptoms in the observation group were significantly lower than those in the control group(P<0.05).The levels of salivary interleukin-6(IL-6),interleukin-8(IL-8)and tumor necrosis factor-α(TNF-α)in the observation group were significantly lower than those in the control group(P<0.05).After treatment,levels of CD4+ and CD4+/CD8+ in the observation group were significantly higher than those in the control group,and level of CD8+ was significantly lower than that in the control group(P<0.05).There was no significant difference in the total incidence of adverse reactions between the two groups(P>0.05).The recurrence rate of the observation group was significantly lower than that in the control group(P<0.05).Conclusion:Modified Xiaoyao powder combined with triamcinolone acetonide can effectively improve the therapeutic effect of OLP patients with Ganyu Xueyu,further alleviate clinical symptoms of patients,reduce recurrence rate and level of salivary inflammatory factors,improve immune function of the body and better safety.

参考文献/References:

[1] WARNAKULASURIYA S,KUJAN O,AGUIRRE J M,et al.Oral potentially malignant disorders:A consensus report from an international seminar on nomenclature and classification convened by the WHO collaborating centre for oral cancer[J].Oral Dis,2021,27(8):1862-1880.
[2] HOWATI A,THORNHILL M H,COLLEY H E,et al.Immune mechanisms in oral lichen planus[J].Oral Dis,2023,29(4):1400-1415.
[3] SALINAS G C,GOMEZ G F,GALERA M F,et al.Photodynamic therapy photobiomodulation and acetonide triamcinolone 0.1% in the treatment of oral lichen planus:A randomized clinical trial[J].Pharmaceutics,2022,15(1):30.
[4] 李雨薇,张紫欣,何焌,等.曲安奈德应用于口腔扁平苔藓的不良反应及其应对策略的研究进展[J].中国医师杂志,2022,24(7):1119-1120.
[5] 邓倩澜,路月亭,路华林,等.基于网络药理学和分子对接研究化湿行瘀清热方治疗口腔扁平苔藓的作用机制[J].河北中医,2021,43(7):1195-1204.
[6] 金怡,徐勤业.雷公藤多苷片联合西药及康复新液治疗糜烂型口腔扁平苔藓脾胃湿热证临床研究[J].新中医,2023,55(7):151-154.
[7] 中华口腔医学会口腔黏膜病学专业委员会,中华口腔医学会中西医结合专业委员会.口腔扁平苔藓诊疗指南(修订版)[J].中华口腔医学杂志,2022,57(2):115-121.
[8] 徐治鸿.中西医结合口腔黏膜病学[M].北京:人民卫生出版社,2008:283-295.
[9] 朱文锋.中医诊断学[M].北京:中国中医药出版社,2007:153-203.
[10] 周刚,刘宏伟,林梅,等.口腔扁平苔藓(萎缩型、糜烂型)疗效评价标准(试行)[J].中华口腔医学杂志,2005,40(2):92-93.
[11] JUNG W,JANG S.Oral microbiome research on oral lichen planus:Current findings and perspectives[J].Biology,2022,11(5):723.
[12] 张宁馨,孙娴,何焌,等.雷公藤多苷联合西医治疗口腔扁平苔藓的研究进展[J].中国临床实用医学,2022,13(2):79-80.
[13] 王蕊,王芹,杜文斌,等.解毒愈溃汤联合曲安奈德对糜烂型口腔扁平苔藓的治疗效果[J].贵州医科大学学报,2020,45(3):335-339,344.
[14] 鄢玲,项鹏飞.清利湿热方联合曲安奈德对口腔扁平苔藓患者血清炎症因子及sIL-2R水平的影响分析[J].四川中医,2019,37(6):162-165.
[15] 刘小瑶,张雪,吕玺,等.基于网络药理学和分子对接探讨逍遥散抗抑郁的作用机制[J].湖南中医杂志,2023,39(3):148-157,190.
[16] 吕成龙,李会会,史永洁,等.中药当归现代研究进展及其质量标志物的预测分析[J].中国中药杂志,2022,47(19):5140-5157.
[17] 李力恒,陈丽萍,胡晓阳,等.柴胡的化学成分及药理作用研究进展[J].中医药学报,2023,51(2):109-112.
[18] 陈燕伟,马善波,权伟,等.柴胡皂苷D对慢性应激诱导小鼠焦虑症的影响[J].陕西中医,2021,42(6):705-708.
[19] 石博宇,叶晓林,罗杰,等.逍遥散对脂多糖诱导抑郁样行为的影响[J].中成药,2019,41(4):760-766.
[20] 郑舒,何津,单延红.逍遥散联合维生素D对产后抑郁大鼠行为学及脑组织形态学的影响[J].陕西中医,2021,42(10):1333-1337.
[21] 李洁婷,欧阳瑾.白芍总苷配合丹栀逍遥散对口腔扁平苔藓患者的疗效及心理状态分析[J].中国处方药,2020,18(6):130-131.
[22] 李新,孙银银,潘英潇,等.口腔扁平苔藓患者唾液中氧化应激指标与NF-κB相关炎症因子相关性的研究[J].口腔医学研究,2019,35(12):1187-1190.
[23] 王安训.口腔黏膜相关疾病免疫功能检测及意义[J].口腔疾病防治,2021,29(2):73-80.
[24] 丁旭,陆丽荣,周兰英,等.口腔扁平苔藓患者血清白介素-17、P物质、趋化素水平与疾病活动和免疫功能的关系研究[J].现代生物医学进展,2022,22(10):1865-1868.
[25] 刘亚娟,张文涛.口腔扁平苔藓患者血清NGF、sPD-1、RANTES 水平与免疫功能的相关性分析[J].检验医学与临床,2022,19(10):1386-1389.

备注/Memo

备注/Memo:
基金项目:西藏自治区自然科学基金资助项目[XZ2019ZR-ZY39(Z)]
更新日期/Last Update: 2024-07-09